Background and Aims: Labour pain is considered a key stimulus for the release of β-endorphins in parturients. This study aimed to evaluate differences in maternal serum β-endorphin levels in response to varying pain intensities across different delivery trajectories: caesarean delivery without labour pain, caesarean delivery following the onset of labour pain, and vaginal delivery. Methods: Serum β-endorphin levels were measured in 60 parturients: 20 undergoing caesarean delivery without labour pain (Group CD-NL), 20 undergoing caesarean delivery following the onset of labour pain (Group CD-L), and 20 undergoing vaginal delivery (Group VD) at four time points: pre-labour (S1), immediately postpartum (S2), and at 30 minutes (S3) and 60 minutes (S4) following delivery. β-endorphin levels were compared between groups. The temporal trends within each group were analysed. Labour pain in Group VD and Group CD-L was assessed using an 11-point numeric rating scale and correlated with β-endorphin levels at S2. Results: Of the 120 participants screened, 60 completed the study. Kruskal–Wallis test demonstrated no significant differences in β-endorphin levels among the three groups at S2, S3, and S4 ( P = 0.39, 0.49, and 0.43, respectively). Intra-group analysis showed no significant temporal changes in any group. A weak positive, statistically insignificant correlation was noted between pain scores and β-endorphin levels in Group VD (r = 0.36, P = 0.125), and there was no correlation in Group CD-L (r = 0.00, P = 0.958). Conclusion: Peripartum serum β-endorphin levels were not influenced by labour pain intensity across various delivery trajectories in the study population.
Background and Aims: Cough is frequently encountered during extubation. We propose a novel technique of utilising the suction port of a subglottic suction drainage endotracheal tube (SSD-ETT) to instil lignocaine around the cuff and improve tube tolerance during extubation. The primary objective was to assess the cough score during emergence. Secondary objectives included changes in haemodynamics and postoperative oropharyngeal morbidities. Methods: In total, 108 patients undergoing nasal surgery were tracheally intubated with the SSD-ETT and randomised to receive normal saline (NS) both intravenous and subglottic (Group C), subglottic NS and intravenous lignocaine (Group IVL), and subglottic lignocaine and intravenous NS (Group SGL) before reversal of residual neuromuscular blockade. The volume for subglottic administration was fixed at 3 mL of either 2% lignocaine or NS. The volume for intravenous administration was 1.5 mg/kg of 2% lignocaine or an equivalent volume of NS. Tube tolerance was graded using a 5-point qualitative cough score. Haemodynamics were recorded at baseline, post-intubation, and post-extubation. Postoperative oropharyngeal morbidities were also compared. Results: Seventy-five percent of patients in Group SGL had no cough, compared to 27.8% in Group IVL and 30% in Group C ( P < 0.001). The heart rate immediately following extubation was significantly lower ( P = 0.006) in Group SGL: 96 [standard deviation (SD): 19)] [95% confidence interval (CI): 90, 103] beats/min when compared with Group C: 107 (SD: 15) (95% CI: 102, 112) and Group IVL: 108 (SD: 18) (95% CI: 102, 114). The mean arterial pressure and oropharyngeal morbiditiy were comparable ( P > 0.05). Conclusion: Subglottic instillation of lignocaine significantly improves tube tolerance during extubation and has favourable effects on heart rate compared to intravenous administration.